Trials / Unknown
UnknownNCT05834699
HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC
An Exploratory Clinical Study of HER2 Expression of Circulating Tumor Cells : Predictive and Prognostic Value in HER2-low Advanced Breast Cancer Patients Treated With ADC
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Beijing 302 Hospital · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate the predictive and prognostic value of HER2 expression of circulating tumor cells in HER2-low advanced breast cancer patients treated with ADC
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HER2 expression of circulating tumor cells | Detect HER2 expression of circulating tumor cells dynamically during ADC-based treatment in HER2-low ABC |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2024-12-01
- Completion
- 2025-04-01
- First posted
- 2023-04-28
- Last updated
- 2023-04-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05834699. Inclusion in this directory is not an endorsement.